Video-assisted thoracoscopic surgery (VATS) has been used recently in the d
iagnosis and management of thoracic diseases. In this report, VATS experien
ce with 95 cases, focusing on indications, surgical procedures, complicatio
ns, and failure rates, are reviewed. Over the past 5 years, 95 VATS procedu
res for diagnostic and therapeutic purposes were performed in 59 men and 36
women. The specific indications for VATS were lung biopsy for undiagnosed
diffuse lung disease (48), mediastinal biopsy (12) and cyst (2), pleural ef
fusion (10), empyema (5), pneumothorax and bullous lung disease (6), perica
rdial effusion (2) and cyst (2), paravertebral abscess (2), solitary pulmon
ary nodules (3), and thoracic trauma (3). In all patients, postoperative pa
in was controlled with non-narcotic analgesics and was measured according t
o the visual analogue scale (VAS). There was no surgical mortality. Postope
rative nonfatal complications were seen in seven cases (7.5%). The overall
median duration of chest tube drainage was 2.7 days and the mean postoperat
ive hospital stay was 3 days. For diffuse lung disease, a tissue diagnosis
was obtained in all the cases. Definitive diagnosis in the patients with un
diagnosed pleural effusion was obtained in 90% of cases, and the overall di
agnostic rate was 98.5%. The success rate of the therapeutic procedures was
100% after a mean follow-up of 12 months (range, 6-30 months). Conversion
to thoracotomy was needed in six cases (6.6%). All patients scored postoper
ative pain <50% according to the VAS. Video-assisted thoracoscopic surgery
should be considered as a procedure of choice, with exceptional results in
the following chest diseases: (a) undiagnosed pleural effusions; (b) recurr
ent, post-traumatic, or complicated spontaneous pneumothorax; (c) stage II
empyema; (d) accurate staging of lung cancer; (e) emergency traumatic injur
ies of the chest; (f) peripheral solitary pulmonary nodule <3 cm; and (g) l
ung biopsy for pulmonary diffuse disease.